Cargando…
Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma
This retrospective, single-institutional study investigated long-term outcome, toxicity and health-related quality of life (HRQoL) in meningioma patients after radiotherapy. We analyzed the data of 119 patients who received radiotherapy at our department from 1997 to 2014 for intracranial WHO grade...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672325/ https://www.ncbi.nlm.nih.gov/pubmed/36396802 http://dx.doi.org/10.1038/s41598-022-24192-8 |
_version_ | 1784832707865346048 |
---|---|
author | Lisowski, Dominik Trömel, Jannik Lutyj, Paul Lewitzki, Victor Hartrampf, Philipp E. Polat, Bülent Flentje, Michael Tamihardja, Jörg |
author_facet | Lisowski, Dominik Trömel, Jannik Lutyj, Paul Lewitzki, Victor Hartrampf, Philipp E. Polat, Bülent Flentje, Michael Tamihardja, Jörg |
author_sort | Lisowski, Dominik |
collection | PubMed |
description | This retrospective, single-institutional study investigated long-term outcome, toxicity and health-related quality of life (HRQoL) in meningioma patients after radiotherapy. We analyzed the data of 119 patients who received radiotherapy at our department from 1997 to 2014 for intracranial WHO grade I-III meningioma. Fractionated stereotactic radiotherapy (FSRT), intensity modulated radiotherapy (IMRT) or radiosurgery radiation was applied. The EORTC QLQ-C30 and QLQ-BN20 questionnaires were completed for assessment of HRQoL. Overall survival (OS) for the entire study group was 89.6% at 5 years and 75.9% at 10 years. Local control (LC) at 5 and 10 years was 82.4% and 73.4%, respectively. Local recurrence was observed in 22 patients (18.5%). Higher grade acute and chronic toxicities were observed in seven patients (5.9%) and five patients (4.2%), respectively. Global health status was rated with a mean of 59.9 points (SD 22.3) on QLQ-C30. In conclusion, radiotherapy resulted in very good long-term survival and tumor control rates with low rates of severe toxicities but with a deterioration of long-term HRQoL. |
format | Online Article Text |
id | pubmed-9672325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96723252022-11-19 Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma Lisowski, Dominik Trömel, Jannik Lutyj, Paul Lewitzki, Victor Hartrampf, Philipp E. Polat, Bülent Flentje, Michael Tamihardja, Jörg Sci Rep Article This retrospective, single-institutional study investigated long-term outcome, toxicity and health-related quality of life (HRQoL) in meningioma patients after radiotherapy. We analyzed the data of 119 patients who received radiotherapy at our department from 1997 to 2014 for intracranial WHO grade I-III meningioma. Fractionated stereotactic radiotherapy (FSRT), intensity modulated radiotherapy (IMRT) or radiosurgery radiation was applied. The EORTC QLQ-C30 and QLQ-BN20 questionnaires were completed for assessment of HRQoL. Overall survival (OS) for the entire study group was 89.6% at 5 years and 75.9% at 10 years. Local control (LC) at 5 and 10 years was 82.4% and 73.4%, respectively. Local recurrence was observed in 22 patients (18.5%). Higher grade acute and chronic toxicities were observed in seven patients (5.9%) and five patients (4.2%), respectively. Global health status was rated with a mean of 59.9 points (SD 22.3) on QLQ-C30. In conclusion, radiotherapy resulted in very good long-term survival and tumor control rates with low rates of severe toxicities but with a deterioration of long-term HRQoL. Nature Publishing Group UK 2022-11-17 /pmc/articles/PMC9672325/ /pubmed/36396802 http://dx.doi.org/10.1038/s41598-022-24192-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lisowski, Dominik Trömel, Jannik Lutyj, Paul Lewitzki, Victor Hartrampf, Philipp E. Polat, Bülent Flentje, Michael Tamihardja, Jörg Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma |
title | Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma |
title_full | Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma |
title_fullStr | Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma |
title_full_unstemmed | Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma |
title_short | Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma |
title_sort | health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672325/ https://www.ncbi.nlm.nih.gov/pubmed/36396802 http://dx.doi.org/10.1038/s41598-022-24192-8 |
work_keys_str_mv | AT lisowskidominik healthrelatedqualityoflifeandclinicaloutcomeafterradiotherapyofpatientswithintracranialmeningioma AT tromeljannik healthrelatedqualityoflifeandclinicaloutcomeafterradiotherapyofpatientswithintracranialmeningioma AT lutyjpaul healthrelatedqualityoflifeandclinicaloutcomeafterradiotherapyofpatientswithintracranialmeningioma AT lewitzkivictor healthrelatedqualityoflifeandclinicaloutcomeafterradiotherapyofpatientswithintracranialmeningioma AT hartrampfphilippe healthrelatedqualityoflifeandclinicaloutcomeafterradiotherapyofpatientswithintracranialmeningioma AT polatbulent healthrelatedqualityoflifeandclinicaloutcomeafterradiotherapyofpatientswithintracranialmeningioma AT flentjemichael healthrelatedqualityoflifeandclinicaloutcomeafterradiotherapyofpatientswithintracranialmeningioma AT tamihardjajorg healthrelatedqualityoflifeandclinicaloutcomeafterradiotherapyofpatientswithintracranialmeningioma |